These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4229 related articles for article (PubMed ID: 2494733)

  • 21. Boron neutron capture therapy of a murine melanoma.
    Coderre JA; Kalef-Ezra JA; Fairchild RG; Micca PL; Reinstein LE; Glass JD
    Cancer Res; 1988 Nov; 48(22):6313-6. PubMed ID: 3180048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview: radiation sources, beam quality, dosimetry and spectroscopy in neutron capture therapy.
    Kanda K
    Strahlenther Onkol; 1989; 165(2-3):67-9. PubMed ID: 2494745
    [No Abstract]   [Full Text] [Related]  

  • 23. Research reactor adaptation project for neutron capture therapy.
    Sauer IL; de Souza JA; Montagno Ede A; Hatanaka H
    Strahlenther Onkol; 1989; 165(2-3):81-3. PubMed ID: 2494750
    [No Abstract]   [Full Text] [Related]  

  • 24. [Neutron capturing irradiation: principle, current results and perspectives].
    Pignol JP; Chauvel P
    Bull Cancer Radiother; 1995; 82(3):283-97. PubMed ID: 8554878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated approach in the planning of neutron capture therapy.
    Ryabukhin YS
    Strahlenther Onkol; 1989; 165(2-3):158-62. PubMed ID: 2494721
    [No Abstract]   [Full Text] [Related]  

  • 26. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent.
    Matalka KZ; Bailey MQ; Barth RF; Staubus AE; Soloway AH; Moeschberger ML; Coderre JA; Rofstad EK
    Cancer Res; 1993 Jul; 53(14):3308-13. PubMed ID: 8324742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Selective affinity of 10B1-paraboronophenylalanine-HCl to malignant melanoma: thermal neutron capture therapy].
    Tsuji M; Ichihashi M; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1983 Jun; 93(7):773-8. PubMed ID: 6620640
    [No Abstract]   [Full Text] [Related]  

  • 28. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental boron neutron capture therapy for melanoma: systemic delivery of boron to melanotic and amelanotic melanoma.
    Coderre JA; Glass JD; Packer S; Micca P; Greenberg D
    Pigment Cell Res; 1990 Dec; 3(6):310-8. PubMed ID: 2101931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides.
    Yoshino K; Suzuki A; Mori Y; Kakihana H; Honda C; Mishima Y; Kobayashi T; Kanda K
    Strahlenther Onkol; 1989; 165(2-3):127-9. PubMed ID: 2928932
    [No Abstract]   [Full Text] [Related]  

  • 31. Boron neutron capture therapy induces cell cycle arrest and DNA fragmentation in murine melanoma cells.
    Faião-Flores F; Coelho PR; Arruda-Neto J; Maria DA
    Appl Radiat Isot; 2011 Dec; 69(12):1741-4. PubMed ID: 21441034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Head phantom experiment and calculation for NCT using various neutron beams.
    Matsumoto T; Aizawa O
    Strahlenther Onkol; 1989; 165(2-3):98-100. PubMed ID: 2494756
    [No Abstract]   [Full Text] [Related]  

  • 33. In situ measurement on 10B concentrations and absorbed dose estimations in human malignant melanoma treated by BNCT.
    Kobayashi T; Kanda K; Mishima Y
    Strahlenther Onkol; 1989; 165(2-3):104-6. PubMed ID: 2494708
    [No Abstract]   [Full Text] [Related]  

  • 34. Preloading with L-tyrosine increases the uptake of boronophenylalanine in mouse melanoma cells.
    Papaspyrou M; Feinendegen LE; Müller-Gärtner HW
    Cancer Res; 1994 Dec; 54(24):6311-4. PubMed ID: 7987818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological effects of intermediate-energy neutrons and their relevance to boron neutron capture therapy.
    Mill AJ
    Strahlenther Onkol; 1989; 165(2-3):193-6. PubMed ID: 2494726
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
    Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutron capture therapy for melanoma.
    Coderre JA; Glass JD; Micca P; Fairchild RG
    Basic Life Sci; 1989; 50():219-32. PubMed ID: 2751612
    [No Abstract]   [Full Text] [Related]  

  • 38. Boron nanoparticles inhibit tumour growth by boron neutron capture therapy in the murine B16-OVA model.
    Petersen MS; Petersen CC; Agger R; Sutmuller M; Jensen MR; Sørensen PG; Mortensen MW; Hansen T; Bjørnholm T; Gundersen HJ; Huiskamp R; Hokland M
    Anticancer Res; 2008; 28(2A):571-6. PubMed ID: 18506994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
    Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological efficacy of a boronated porphyrin as measured in cell culture.
    Laster BH; Kahl SB; Kalef-Ezra J; Popenoe EA; Fairchild RG
    Strahlenther Onkol; 1989; 165(2-3):203-5. PubMed ID: 2494728
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 212.